Position in TGTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,743,362
+$2,605,992 QoQ
Shares Held
112,684
+195.3% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Dec 31, 2025CallValue
$593,219
CallShares
19,900
PutValue
$473,979
PutShares
15,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $292,594,996 across 34 Biotechnology names. TGTX ranks #16 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122,934 | $54,894,948 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
140,109 | $46,357,864 | |
| 3 | INCY |
Incyte Corp
|
312,021 | $29,367,416 | |
| 4 | MRNA |
Moderna, Inc.
|
569,930 | $28,952,444 | |
| 5 | EXEL |
Exelixis, Inc.
|
479,693 | $20,574,032 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
174,378 | $11,270,050 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
142,201 | $10,677,873 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
181,065 | $10,228,361 |
All Filings in TGTX
Export CSV
36 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,743,362 | 112,684 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $593,219 | 19,900 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $473,979 | 15,900 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $1,137,370 | 38,154 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $570,775 | 15,800 | Call | Sole | 2025-11-13 | |
| 2025-09-30 | $541,875 | 15,000 | Put | Sole | 2025-11-13 | |
| 2025-09-30 | $4,393,558 | 121,621 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $914,146 | 25,400 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $795,379 | 22,100 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $1,969,444 | 54,722 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,628,459 | 41,300 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $824,087 | 20,900 | Put | Sole | 2025-05-14 | |
| 2024-12-31 | $8,485,190 | 281,900 | Call | Sole | 2025-02-13 | |
| 2024-12-31 | $686,280 | 22,800 | Put | Sole | 2025-02-13 | |
| 2024-09-30 | $7,498,834 | 320,600 | Call | Sole | 2024-11-13 | |
| 2024-09-30 | $989,397 | 42,300 | Put | Sole | 2024-11-13 | |
| 2024-09-30 | $3,083,527 | 131,831 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,550,076 | 424,400 | Call | Sole | 2024-08-13 | |
| 2024-06-30 | $1,869,729 | 105,100 | Put | Sole | 2024-08-13 | |
| 2024-06-30 | $6,922,498 | 389,123 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,039,188 | 462,800 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $941,499 | 61,900 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $508,211 | 33,413 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,032,588 | 236,100 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $19,541,228 | 1,144,100 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $3,519,560 | 421,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $673,966 | 80,618 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $914,584 | 109,400 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $6,699,348 | 269,700 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $4,563,108 | 183,700 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $2,967,392 | 197,300 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $2,144,704 | 142,600 | Put | Sole | 2023-05-15 | |
| 2022-12-31 | $620,720 | 52,470 | Shares | Sole | 2023-02-13 | |
| 2021-09-30 | $462,592 | 13,900 | Call | Sole | 2021-11-12 | |
| 2021-09-30 | $875,264 | 26,300 | Put | Sole | 2021-11-12 | |
| 2020-12-31 | $678,028 | 13,034 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||